BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $190,879 | $214,737 | $204,279 | $228,960 |
| - Cash | $71 | $1 | $1 | $1 |
| + Debt | $278 | $1,029 | $61 | $0 |
| Enterprise Value | $191,086 | $215,765 | $204,339 | $228,959 |
| Revenue | $24,456 | -$384 | $18,291 | $16,605 |
| % Growth | 6,471% | -102.1% | 10.1% | – |
| Gross Profit | $27,542 | -$3,470 | $15,272 | $13,602 |
| % Margin | 112.6% | 904% | 83.5% | 81.9% |
| EBITDA | -$22,469 | $45,973 | $8,711 | $11,314 |
| % Margin | -91.9% | -11,976.7% | 47.6% | 68.1% |
| Net Income | -$22,492 | $45,947 | $8,707 | $11,310 |
| % Margin | -92% | -11,969.7% | 47.6% | 68.1% |
| EPS Diluted | -1.53 | 3.3 | 0.62 | 0.81 |
| % Growth | -146.4% | 432.3% | -23.5% | – |
| Operating Cash Flow | $78,910 | -$13,388 | -$1,749 | $6,514 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | $78,910 | -$13,388 | -$1,749 | $6,514 |